DE202007002226U1 - Topical composition, useful in wound treatment e.g. bruise and burn, comprises three trace elements such as cobalt, zinc, chromium, iron, manganese, copper, molybdenum, selenium and/or vanadium - Google Patents

Topical composition, useful in wound treatment e.g. bruise and burn, comprises three trace elements such as cobalt, zinc, chromium, iron, manganese, copper, molybdenum, selenium and/or vanadium Download PDF

Info

Publication number
DE202007002226U1
DE202007002226U1 DE202007002226U DE202007002226U DE202007002226U1 DE 202007002226 U1 DE202007002226 U1 DE 202007002226U1 DE 202007002226 U DE202007002226 U DE 202007002226U DE 202007002226 U DE202007002226 U DE 202007002226U DE 202007002226 U1 DE202007002226 U1 DE 202007002226U1
Authority
DE
Germany
Prior art keywords
selenium
vanadium
molybdenum
manganese
cobalt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE202007002226U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHULTZ HANS ALBERT
Original Assignee
SCHULTZ HANS ALBERT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHULTZ HANS ALBERT filed Critical SCHULTZ HANS ALBERT
Priority to DE202007002226U priority Critical patent/DE202007002226U1/en
Publication of DE202007002226U1 publication Critical patent/DE202007002226U1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates

Abstract

Composition (C1), for topical application, preferably on skin, mucous membrane and scalp, comprises at least three trace elements e.g. cobalt, zinc, chromium, iron, manganese, copper, molybdenum, selenium and/or vanadium. An independent claim is also included for a wound levy comprising (C1). ACTIVITY : Vulnerary; Hemostatic; Gastrointestinal-Gen. The ability of the composition to treat wound was tested in female patient of 16 years. The result showed that the wound was cleared within 3-4 days without any scars on the skin, after the applying the composition. MECHANISM OF ACTION : None given.
DE202007002226U 2007-02-12 2007-02-12 Topical composition, useful in wound treatment e.g. bruise and burn, comprises three trace elements such as cobalt, zinc, chromium, iron, manganese, copper, molybdenum, selenium and/or vanadium Expired - Lifetime DE202007002226U1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE202007002226U DE202007002226U1 (en) 2007-02-12 2007-02-12 Topical composition, useful in wound treatment e.g. bruise and burn, comprises three trace elements such as cobalt, zinc, chromium, iron, manganese, copper, molybdenum, selenium and/or vanadium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE202007002226U DE202007002226U1 (en) 2007-02-12 2007-02-12 Topical composition, useful in wound treatment e.g. bruise and burn, comprises three trace elements such as cobalt, zinc, chromium, iron, manganese, copper, molybdenum, selenium and/or vanadium

Publications (1)

Publication Number Publication Date
DE202007002226U1 true DE202007002226U1 (en) 2007-04-12

Family

ID=37983256

Family Applications (1)

Application Number Title Priority Date Filing Date
DE202007002226U Expired - Lifetime DE202007002226U1 (en) 2007-02-12 2007-02-12 Topical composition, useful in wound treatment e.g. bruise and burn, comprises three trace elements such as cobalt, zinc, chromium, iron, manganese, copper, molybdenum, selenium and/or vanadium

Country Status (1)

Country Link
DE (1) DE202007002226U1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011160443A1 (en) * 2010-06-24 2011-12-29 攀枝花东方微元科技有限公司 Pharmaceutical composition comprising vanadium and its use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011160443A1 (en) * 2010-06-24 2011-12-29 攀枝花东方微元科技有限公司 Pharmaceutical composition comprising vanadium and its use

Similar Documents

Publication Publication Date Title
Polefka et al. Interaction of mineral salts with the skin: a literature survey
WO2005079822A3 (en) Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds
WO2009088726A3 (en) Mucosal tissue dressing and method of use
WO2007089454A3 (en) Methods for enhancing skin treatments
WO2009149369A3 (en) Acne treatment compositions comprising nanosilver and uses
WO2009019499A3 (en) Improvements relating to skin dressings
EA200801717A1 (en) LOCAL APPLICATION COMPOSITION FOR SKIN CARE, PRODUCT ON ITS BASIS AND METHOD OF TREATMENT
SG158112A1 (en) Hepatocyte growth factor (hgf) binding proteins
ATE281150T1 (en) ACNE TREATMENT REMEDIES
WO2006062679A3 (en) Bandage and method for vital bleaching of skin
WO2011059324A3 (en) Composition for topical application, uses thereof, applicator device and kit of parts
WO2007100555A3 (en) Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
WO2008096203A3 (en) Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
WO2008092011A3 (en) Biofilm-inhibiting medical products
WO2006124686A3 (en) Modulation of stat 6 expression for the treatment of airway hyperresponsiveness
WO2006136428A3 (en) Method and composition to treat skin ulcers
DE202007002226U1 (en) Topical composition, useful in wound treatment e.g. bruise and burn, comprises three trace elements such as cobalt, zinc, chromium, iron, manganese, copper, molybdenum, selenium and/or vanadium
JP2010184900A (en) Hircismus preventing article and method for producing the same
ATE553760T1 (en) USE OF ALVERINE TO TREAT SKIN DISEASES
ATE499944T1 (en) USE OF AN EXTRACT OF A NON-PHOTOSYNTHETIC FIBROUS BACTERIUM FOR PROMOTING THE PRODUCTION OF SUPEROXIDE DISMUTASE
WO2009106555A3 (en) Sterilized sucralfate gel
CO5060466A1 (en) METHOD OF REDUCTION OR PREVENTION OF EVIL ODOR
WO2004105689A3 (en) Topical composition for the treatment of skin disorders and methods of using the same
Farroha et al. Use of biobrane® to dress split-thickness skin graft adjacent to skin graft donor sites or partial-thickness burns
AU2015268649B2 (en) A composition and method of applying same & a composition that assists healing burns and wounds with antibacterial and anti-fungal actions

Legal Events

Date Code Title Description
R207 Utility model specification

Effective date: 20070516

R156 Lapse of ip right after 3 years

Effective date: 20100901